Efficacy of 23-valent pneumococcal polysaccharide vaccine in preventing community-acquired pneumonia among immunocompetent adults: A systematic review and meta-analysis of randomized trials-Reference-Cited by-同舟云学术

Efficacy of 23-valent pneumococcal polysaccharide vaccine in preventing community-acquired pneumonia among immunocompetent adults: A systematic review and meta-analysis of randomized trials

Published:2016-03 Issue:13 Volume:34 Page:1496-1503
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Diao Wen-qi^ORCID,Shen Ning,Yu Pan-xi,Liu Bei-bei,He Bei

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference29 articles.

1. Clinical and economic burden of community-acquired pneumonia among adults in Europe;Welte;Thorax,2012

2. Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques;Said;PLOS ONE,2013

3. The epidemiology of invasive Streptococcus pneumoniae infections in onco-haematology and haematopoietic stem cell transplant patients in France. Are the serotypes covered by the available anti-pneumococcal vaccines?;Debbache;Clin Microbiol Infect: Off Publ Eur Soc Clin Microbiol Infect Dis,2009

4. Serotypes/groups distribution and antimicrobial resistance of invasive pneumococcal isolates: implications for vaccine strategies;Kyaw;Epidemiol Infect,2000

5. Vaccines for preventing pneumococcal infection in adults;Moberley;Cochrane Database Syst Rev,2013

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) in Preventing Community-Acquired Pneumonia in Adults: A Population-Based Cohort Study;Vaccines;2024-09-06

2. Vaccines for the Elderly and Vaccination Programs in Europe and the United States;Vaccines;2024-05-22

3. Persistence of antibody to 23-valent pneumococcal polysaccharide vaccine: a 5-year prospective follow-up cohort study;Expert Review of Vaccines;2024-02-19

4. Outcomes among Thai children with risk conditions hospitalized for pneumococcal disease (invasive or non-bacteraemic pneumonia): A multi-centre, observational study;IJID Regions;2023-09

5. Duration of Protection From Pneumonia After Pneumococcal Vaccination in Hemodialysis Patients (DOPPIO): Protocol for a Prospective Multicenter Study;JMIR Research Protocols;2023-07-12